In Print

Opinion Editorials

Cancer in 2009 — What Needs to be Done - An American diagnosed with cancer today is very likely to join the growing ranks of survivors, who are estimated to total 12 million and will reach 18 million by 2020. The five-year survival rate for all forms of cancer combined has risen to 66%, more than double what it was 50 years ago. Houston Chronicle, 01/25/09

New Hope: Investing in the Cancer Revolution- A profound revolution is under way in the diagnosis, prevention and treatment of cancer. Scientists and physicians are looking beyond our current treatments that have meant survival for millions of patients. We envision applying new knowledge and technologies to improve these therapies with a more personalized approach. Houston Chronicle, 03/10/07

Unsafe at Any Level: Why We Need Wider Smoking Law- Passing a stronger smoking ordinance that will keep people from breathing secondhand smoke in restaurants, bars and most indoor public places should be a high priority for Houston City Council this month. Houston Chronicle, 10/14/06

Viewpoint: Shortening the Timeline for New Cancer Therapy- I write as a specialist in cancer, but the lessons learned in addressing this disease are widely applicable. The "war on cancer" began in 1971 with bipartisan legislation that provided NIH funding for increased research on the cause, prevention and treatment of cancer. The majority of this funding was allocated to basic research, and the results have been spectacular. AAMC Reporter, 08/2004

News Releases

Mendelsohns Honored for Advancing Education, Supporting Teach for America
When Anne and Dr. John Mendelsohn arrived in Houston in 1996 from New York City, little did the city realize that it was getting a pair of enthusiastic community leaders whose diverse interests and contributions extended well beyond The University of Texas M. D. Anderson Cancer Center. 10/20/08

Mendelsohn Honored for Taking New Therapy from Concept to Clinic
For his research illuminating the role of growth factors in cancer cell proliferation, developing a completely new field of therapy to block that process, and then advancing the first drug of its kind to the clinic, University of Texas M. D. Anderson Cancer Center President John Mendelsohn, M.D., has earned a top award from his peers in the American Association for Cancer Research. 04/16/08

International Award Honors M. D. Anderson President for Pioneering Research- For his breakthrough research in cancer therapy, John Mendelsohn, M.D., president of The University of Texas M. D. Anderson Cancer Center, has been named co-recipient of a 2006 Dan David Prize, which was announced in Paris. 02/27/06

Annual Chaplaincy Event to Honor KPRC's Linda Lorelle, Dr. John Mendelsohn- The 13th annual "Loving Hearts and Caring Hands" awards dinner, benefiting the Department of Chaplaincy and Pastoral Education at The University of Texas M. D. Anderson Cancer Center, will honor local KPRC-TV news-anchor Linda Lorelle and M. D. Anderson's own President John Mendelsohn, M.D., on the evening of Jan. 17 at the Intercontinental Houston Hotel, 2222 West Loop South. 01/11/06

Wilson Center to Honor Anne and John Mendelsohn and Cheryl and Philip Burguières With Awards for Public Service and Corporate Citizenship- Four distinguished leaders will be honored with Woodrow Wilson Awards for their exceptional service and contributions to their community and country on Tuesday, April 26, 2005. 04/22/05

Mendelsohn Tenure as Clinical Cancer Research Editor-in-Chief Spans a Decade- In 1995, the new phrase in oncology was “translational research” - a movement to quickly bring therapies based on the fruits of the molecular revolution to cancer patients. To shepherd such research, a new scientific cancer journal called Clinical Cancer Research was born. 12/15/04

M. D. Anderson's President Honored With Prestigious Award From the American Society of Clinical Oncology- Dr. John Mendelsohn, president of The University of Texas M. D. Anderson Cancer Center, will receive the David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (ASCO) for his pioneering research in the development of monoclonal antibodies to block growth factor receptors. 05/18/02

Mendelsohn Has ‘Big Plans’ for the Future of M. D. Anderson - As the third president of The University of Texas M. D. Anderson Cancer Center - following Dr. R. Lee Clark who served 1946-1978 and Dr. Charles A. LeMaistre, 1978-1996 - Dr. Mendelsohn stands at the helm as the renowned cancer center celebrates its 60th anniversary during a period of unprecedented growth. 03/27/01